Discovery and Model‐Informed Drug Development of a Controlled‐Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical Pharmacology & Therapeutics

Topics

Chemistry

Medicine

Molecular Biology

Cellular And Molecular Neuroscience

Plasma Concentration

Show all topics

DOI

10.1002/cpt.3311